CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net loss	$ (17,686,472)	$ (7,150,712)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	206,344	313,940
Impairment of intellectual property	114,730
Fair value of vested options issued to officers, directors and employees	1,517,524	1,953,844
Change in fair value of warrant liability	7,508,146
Amortization of capitalized financing costs		85,975
Amortization of debt discount attributable to convertible debentures		541,120
Fair value of vested warrants issued for service	28,256	58,238
Common stock issued in settlement of interest		102,844
Fair value change from employee option modifications	408,605
Bad debt expense	77,415
Change in operating assets and liabilities:
Accounts receivable	(453,059)	(88,407)
Prepaid expenses and deposits	(109,042)	(16,565)
Accounts payable and accrued liabilities	517,200	239,044
Net cash used in operating activities	(7,870,353)	(3,960,679)
Cash flows used in investing activities:
Purchase of assets under RedWeb asset purchase agreement	(584,080)
Purchase of property and equipment	(636,548)	(162,833)
Net cash used in investing activities	(1,220,628)	(162,833)
Cash flows from financing activities:
Net proceeds from sale of Series A and Series B Preferred Stock	10,735,000
Net proceeds from sale of common stock and warrants	3,900,000	2,101,000
Purchase and cancellation of previously issued warrants	(60,000)
Proceeds from exercise of options and warrants	151,500
Net cash provided by financing activities	14,726,500	2,101,000
Net increase (decrease) in cash and cash equivalents	5,635,519	(2,022,512)
Cash and cash equivalents at beginning of year	724,782	2,747,294
Cash and cash equivalents at end of year	6,360,301	724,782
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for income taxes
Non-cash investing and financing transactions:
Fair value of warrants issued for financing costs
Property, plant and equipment acquired, and included in accounts payable	6,273
Common stock issued upon conversion of Series A and Series B preferred stock	67,759
Common stock issued for cashless exercise of options and warrants	49,600
Common stock issued in exchange for previously incurred debt and related accrued interest		$ 4,687,096